New Colon Cancer Gene Licensed Exclusively to Myriad Genetics
Myriad's Predictive Medicine Sample Flow Continues to Grow
14-Apr-2004 -
Salt Lake City. Myriad Genetics, Inc. , announced that it has licensed exclusive rights in the United States to detect mutations in an important new colon cancer gene. Myriad believes that the new colon cancer gene, known as Mut Y Homolog (MYH), will provide improved sensitivity and predictive ...
colon cancer
colorectal cancer
DNA repair
+6